Rapid Development of T Cell Memory Phillip Wong, María Lara-Tejero, Alexander Ploss, Ingrid Leiner and Eric G

Total Page:16

File Type:pdf, Size:1020Kb

Rapid Development of T Cell Memory Phillip Wong, María Lara-Tejero, Alexander Ploss, Ingrid Leiner and Eric G Rapid Development of T Cell Memory Phillip Wong, María Lara-Tejero, Alexander Ploss, Ingrid Leiner and Eric G. Pamer This information is current as J Immunol 2004; 172:7239-7245; ; of October 1, 2021. doi: 10.4049/jimmunol.172.12.7239 http://www.jimmunol.org/content/172/12/7239 References This article cites 30 articles, 12 of which you can access for free at: Downloaded from http://www.jimmunol.org/content/172/12/7239.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision http://www.jimmunol.org/ • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: by guest on October 1, 2021 http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2004 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Rapid Development of T Cell Memory1 Phillip Wong,* Marı´a Lara-Tejero,* Alexander Ploss,*† Ingrid Leiner,* and Eric G. Pamer2* Prime-boost immunization is a promising strategy for inducing and amplifying pathogen- or tumor-specific memory CD8 T cell responses. Although expansion of CD8 T cell populations following the second Ag dose is integral to the prime-boost strategy, it remains unclear when, after priming, memory T cells become competent to proliferate. In this study, we show that Ag-specific CD8 T cells with the capacity to undergo extensive expansion are already present at the peak of the primary immune response in mice. These early memory T cells represent a small fraction of the primary immune response and, at early time points, their potential to proliferate is obscured by large effector T cell populations that rapidly clear Ag upon reimmunization. With sufficient Ag boosting, however, secondary expansion of these memory cells can be induced as early as 5–7 days following primary immuni- zation. Importantly, both early and delayed boosting result in similar levels of protective immunity to subsequent pathogen challenge. Early commitment and differentiation of memory T cells during primary immunization suggest that a short duration between priming and boosting is feasible, providing potential logistic advantages for large-scale prime-boost vaccination of human populations. The Journal of Immunology, 2004, 172: 7239–7245. Downloaded from emory CD8 T cells are essential for immunity to many erate upon re-encountering Ag for 3 wk following priming (13). viral, bacterial, and protozoal pathogens (1). Upon pri- LCMV infection, however, induces extraordinarily large primary M mary activation by foreign Ag, CD8 T cells follow a immune responses (2, 3), and therefore may not reflect the type of program of proliferation and differentiation into CTL armed with T cell priming that occurs with vaccines. effector functions that enable pathogen clearance or containment To explore the kinetics of memory development and the factors http://www.jimmunol.org/ (2–8). After the expansion phase, the majority of Ag-specific CD8 that influence the magnitude of memory cell expansion in the set- T cells undergo programmed cell death, leaving a population of ting of a more typical CD8 T cell response, we examined mice memory CD8 T cells that swiftly proliferate upon secondary an- infected with the intracellular bacterial pathogen Listeria monocy- tigenic challenge. Substantial evidence suggests that CD8 T cells togenes. Peak CD8 T cell responses to L. monocytogenes infection transit through the effector phase before entering the memory pool occur 8 days following bacterial inoculation; subsequently, T cells (9, 10), but it remains unclear when, during the primary immune contract into stable memory populations within 14–21 days (14). response, effector T cells differentiate into long-lived memory In this study, we show that a subset of Ag-specific CD8 T cells can cells. A recent report showed that surface expression of the IL-7R undergo recall proliferative responses upon secondary encounter by guest on October 1, 2021 ␣-chain (IL-7R␣) distinguishes a small population of CD8 effector with Ag within 5–7 days of primary infection, even before the T cells at the peak of the primary response that gives rise to long- primary T cell response begins to subside. Interestingly, we find term memory cells (11); however, it remains unclear when, fol- that the rapid elimination of Ag by effector cells during an ongoing lowing priming, memory T cells acquire the ability to undergo immune response prevents the activation and proliferation of extensive proliferation in response to Ag. Although it was previ- memory cells, explaining the apparent lack of functional memory ously demonstrated that increased CD8 T cell proliferation can be CD8 T cells at early time points after primary immunization. The induced by additional Ag administration within 1 wk following ability of memory T cells to proliferate is revealed, however, when primary bacterial infection (12), a more recent report analyzing the the boosting dose of Ag exceeds the clearance capacity of effector CD8 T cell response to lymphocytic choriomeningitis virus T cells. Remarkably, boosting at early or late time points following (LCMV)3 infection concluded that memory T cells do not prolif- priming is similarly effective at enhancing both the size of sec- ondary memory T cell populations and protective immunity to sub- sequent pathogen challenge. These findings have significant im- *Infectious Diseases Service, Immunology Program, Department of Medicine, Sloan- plications for the design and delivery of prime-boost vaccines. Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10021; and †Immunology Program, Weill Graduate School of Medical Sciences of Cornell University, New York, NY 10021 Materials and Methods Mice, bacteria, and viruses Received for publication December 5, 2003. Accepted for publication March 25, 2004. BALB/cJ were obtained from The Jackson Laboratory (Bar Harbor, ME). The costs of publication of this article were defrayed in part by the payment of page BALB/c Thy-1.1-congenic mice were provided by C. Surh (Scripps Re- charges. This article must therefore be hereby marked advertisement in accordance search Foundation, La Jolla, CA). Wild-type (WT) L. monocytogenes strain with 18 U.S.C. Section 1734 solely to indicate this fact. 10403S, the ActAϪ/Ϫ strain of L. monocytogenes (15) (both provided by D. 1 This work was supported by National Institutes of Health Grants AI-39031 and Portnoy, University of California, Berkeley, CA), and the LLO92Ser mutant AI-42135, an Arthritis Foundation postdoctoral fellowship (to P.W.), and a Cancer strain of L. monocytogenes (mutation of the tyrosine in position 92 of Research Institute predoctoral fellowship (to A.P.). M.L.-T. is a Rosenwald Family/ listeriolysin to a serine (16)) were grown in brain-heart infusion (BHI) DeVaan-Irvington Institute postdoctoral fellow. broth (BD Biosciences, Sparks, MD). Vesicular stomatitis virus (VSV) 2 Address correspondence and reprint requests to Dr. Eric G. Pamer, Memorial Sloan- expressing the L. monocytogenes listeriolysin O (LLO) and p60 epitopes Kettering Cancer Center, 1275 York Avenue, New York, NY 10021. E-mail address: was generated by cloning a PCR-amplified fragment of the L. monocyto- [email protected] genes p60 protein encompassing the p60217–225 and p60449–457 epitopes 3 Abbreviations used in this paper: LCMV, lymphocytic choriomeningitis virus; into pVSV-XN2 (kindly provided by J. Rose, Yale University, New Haven, BHI, brain-heart infusion; LLO, listeriolysin O; VSV, vesicular stomatitis virus; WT, CT) using its unique XhoI and NheI sites. A 64-bp linker encoding wild type. LLO91–99 was then ligated in frame with the p60 fragment at the XhoI site Copyright © 2004 by The American Association of Immunologists, Inc. 0022-1767/04/$02.00 7240 RAPID DEVELOPMENT OF T CELL MEMORY to generate a fusion LLO-p60 protein in pVSV-XN2. Recombinant VSV- immunization (13), an alternative explanation is that the secondary LLO-p60 viruses were then obtained, as previously described (17). Briefly, bacterial challenge is cleared with different kinetics at early and the LLO-p60-containing plasmid was transfected along with pBS-N, late time points following primary infection. Indeed, recent studies pBS-P, and pBS-L helper plasmids into baby hamster kidney cells infected with recombinant vaccinia virus expressing T7 polymerase (vTF7-3). Su- demonstrated that swift activation of Ag-specific T cells following pernatants were recovered 48 h later, spun down to remove debris, and primary infection rapidly eliminates APCs, thereby restricting ad- filtered through a 0.2-␮m filter to remove vTF7-3. The cleared supernatants ditional T cell priming (20, 21). To explore this possibility, we were used to infect baby hamster kidney monolayers. Supernatants were measured in vivo CTL activity using LLO -coated target cells recovered 48 h after the secondary infection, aliquoted, and stored at 91–99 Ϫ80°C. Viral titers were determined by plaque assay. at intervals after primary L. monocytogenes
Recommended publications
  • Immunity ≠ Immunological Memory
    Immunity ≠ Immunological Memory Rolf Zinkernagel University of Zurich IMI Stakeholder Forum - 13 May 2013 - Brussels • Protective vaccines imitate co-evolution of infectious agents and hosts. • We cannot do better than evolution by using the same tools, only when introducing ‘new’ tools (antibiotics, antivirals, autoantibodies, behavioural changes) • Vaccines against solid tumours (carcinomas, sarcomas) and chronic persistent infections are theoretically not impossible but practically highly unlikely! Vaccines Not successful available Polio 1, 2, 3 TB bact. toxins Leprosy measles HIV Haem. infl. malaria (cholera) Neutr. / effector T cells opsonising antibodies antibodies igG (IgA) IMMUNITY • "innate resistance" > 95 % • Ab in eggs • protective memory via Ab (vaccines) • TB: no vaccine • autoimmunity > 30 y, female > male 5 : 1 • tumors > 30 years • Is what we measure biologically important ? (e.g. acad. memory: earlier + greater) CTL ELISA nAb Immunity Immunology Protection • ‚Memory‘ • Small pox • quicker - higher • Poliomeningitis • Measles • HIV, malaria - • Tuberculosis ± Antibody Memory after immunization with VSV a) neutralizing antibodies b) ELISA 12 12 ) 10 ) 10 2 3 8 8 40 log 10 log 6 - - 6 NP binding NP - 4 IND neutralizing 4 - IgG ( IgG ( 2 VSV 2 VSV 0 0 0 20 100 200 300 0 20 100 200 300 days after immunization days after immunization Why immunological Memory ? Protection (immunity) counts ! • Earlier + better • If first infection survived no need for memory • If first infection kills no need for memory • All vaccines that
    [Show full text]
  • NK Cells Remember
    Sweet Is the Memory of Past Troubles: NK Cells Remember Deborah W. Hendricks, Gundula Min-Oo and Lewis L. Lanier Abstract Natural killer (NK) cells are important in host defense against tumors and microbial pathogens. Recent studies indicate that NK cells share many features with the adaptive immune system, and like B cells and T cells, NK cells can acquire immunological memory. Here, we review evidence for NK cell memory and the molecules involved in the generation and maintenance of these self-renewing NK cells that provide enhanced protection of the host. Contents 1 Introduction.............................................................................................................................. 2 Antigen-Specific Recall Responses in a Contact Hypersensitivity Model............................. 2.1 Hepatic NK Cells Acquire Memory to Haptens and Viruslike Particles ...................... 2.2 Insights into the Mechanism of NK Cell Memory in Contact Hypersensitivity and Skin Inflammation ................................................................................................... 3 The Development of NK Cell Memory in Chronic Viral Infections..................................... 3.1 NK Cell Memory Following Mouse Cytomegalovirus Infection .................................. 3.2 NK Cell Memory Following Human Cytomegalovirus Infection ................................. 3.3 Antibody-Dependent Memory-Like NK Cells ............................................................... 3.4 Specificity of NK Cell Memory in Mice and Humans.................................................
    [Show full text]
  • Human Antigen-Specific Memory Natural Killer Cell Responses
    bioRxiv preprint doi: https://doi.org/10.1101/2020.11.09.374348; this version posted November 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Human antigen-specific memory natural killer cell responses develop 2 against HIV-1 and influenza virus and are dependent on MHC-E 3 restriction 4 5 6 Stephanie Jost1, Olivier Lucar1, Taylor Yoder1, Kyle Kroll1, Sho Sugawara1, Scott Smith1, Rhianna 7 Jones1, George Tweet1, Alexandra Werner1, Phillip J. Tomezsko2, Haley L. Dugan2†, Joshua 1 3 3 4 5 8 Ghofrani , Marcus Altfeld , Adam Grundhoff , Michaela Muller-Trutwin , Paul Goepfert , R. Keith 9 Reeves1,2 * 10 11 1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard 12 Medical School, Boston, MA 02115, USA; 2Ragon Institute of Massachusetts General Hospital, 13 MIT, and Harvard, Cambridge, MA 02139, USA; 3Heinrich Pette Institute, Leibniz Institute for 14 Experimental Virology, 20251 Hamburg, Germany; 4Institut Pasteur, HIV, Inflammation and 15 Persistence Unit, Paris, France; 5University of Alabama at Birmingham, Birmingham, AL 35294, 16 USA 17 18 *Corresponding author 19 R. Keith Reeves 20 Center for Virology and Vaccine Research 21 Beth Israel Deaconess Medical Center 22 3 Blackfan Circle 23 Boston, MA 02215 24 Ph: (617-735-4586) 25 Fax: (617-735-4527) 26 E-mail: [email protected] 27 28 †Current address: Committee on Immunology, University of Chicago, Chicago, IL 60637, USA 29 30 Running Title: Human Memory NK Cells 31 32 Abstract: 185 words 33 Main Text: 2713 words 34 Methods Text: 2035 words 35 5 Figures 36 7 Supplemental Figures 37 3 Supplemental Tables 38 62 references 39 40 bioRxiv preprint doi: https://doi.org/10.1101/2020.11.09.374348; this version posted November 10, 2020.
    [Show full text]
  • NK Cell Responses Redefine Immunological Memory
    Th eJournal of Brief Reviews Immunology NK Cell Responses Redefine Immunological Memory Nicholas M. Adams,* Timothy E. O’Sullivan,* Clair D. Geary,* Jenny M. Karo,* Robert A. Amezquita,† Nikhil S. Joshi,† Susan M. Kaech,† and Joseph C. Sun*,‡ Immunological memory has traditionally been regarded theAg-specificnatureoftheseAbtiters(5).Thelampreycan as a unique trait of the adaptive immune system. Nev- also mediate delayed-type hypersensitivity reactions follow- ertheless, there is evidence of immunological memory in ing stimulation with Mycobacterium tuberculosis–fortified lower organisms and invertebrates, which lack an adap- CFA (5). The basis for these phenomena may be attributable tive immune system. Despite their innate ability to rap- to the recently discovered lymphocyte-like populations and idly produce effector cytokines and kill virally infected or variable lymphocyte receptors, akin to primordial T and transformed cells, NK cells also exhibit adaptive charac- B lymphocytes and their Ag receptors, respectively (6, 7). teristics such as clonal expansion, longevity, self-renewal, However, evidence also exists for immunological memory in and robust recall responses to antigenic or nonantigenic invertebrates devoid of an adaptive immune system. Protection stimuli. In this review, we highlight the intracellular and of the American cockroach Periplaneta americana against the extracellular requirements for memory NK cell genera- bacterium Pseudomonas aeruginosa was enhanced by prior immunization with killed P. aeruginosa but not with saline or tion and describe the emerging evidence for memory pre- immunization with an array of other Gram-negative organ- cursor NK cells and their derivation. The Journal of isms (8). Interestingly, this protection against P. aeruginosa Immunology, 2016, 197: 2963–2970.
    [Show full text]
  • Human T Cell Memory: a Dynamic View
    vaccines Review Human T Cell Memory: A Dynamic View Derek C. Macallan 1,2,*, José A. M. Borghans 3 and Becca Asquith 4 1 Institute for Infection & Immunity, St George’s, University of London, Cranmer Terrace, London SW17 0RE, UK 2 St George’s University Hospitals NHS Foundation Trust, Blackshaw Road, London SW17 0QT, UK 3 Laboratory of Translational Immunology, Department of Immunology, University Medical Center Utrecht, P.O. Box 85090, 3508 AB Utrecht, The Netherlands; [email protected] 4 Department of Medicine, Imperial College London W2 1PG, UK; [email protected] * Correspondence: [email protected]; Tel.: +44-208-725-0283; Fax: +44-208-725-3487 Academic Editor: Stephen Todryk Received: 18 July 2016; Accepted: 17 January 2017; Published: 4 February 2017 Abstract: Long-term T cell-mediated protection depends upon the formation of a pool of memory cells to protect against future pathogen challenge. In this review we argue that looking at T cell memory from a dynamic viewpoint can help in understanding how memory populations are maintained following pathogen exposure or vaccination. For example, a dynamic view resolves the apparent paradox between the relatively short lifespans of individual memory cells and very long-lived immunological memory by focussing on the persistence of clonal populations, rather than individual cells. Clonal survival is achieved by balancing proliferation, death and differentiation rates within and between identifiable phenotypic pools; such pools correspond broadly to sequential stages in the linear differentiation pathway. Each pool has its own characteristic kinetics, but only when considered as a population; single cells exhibit considerable heterogeneity.
    [Show full text]
  • The Bone Marrow As Sanctuary for Plasma Cells and Memory T-Cells: Implications for Adaptive Immunity and Vaccinology
    cells Review The Bone Marrow as Sanctuary for Plasma Cells and Memory T-Cells: Implications for Adaptive Immunity and Vaccinology Stefan A. Slamanig 1,2,† and Martijn A. Nolte 1,2,* 1 Department of Molecular Hematology, Sanquin Research, Plesmanlaan 125, 1066 CX Amsterdam, The Netherlands; [email protected] 2 Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands * Correspondence: [email protected] † Current address: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Abstract: The bone marrow (BM) is key to protective immunological memory because it harbors a major fraction of the body’s plasma cells, memory CD4+ and memory CD8+ T-cells. Despite its paramount significance for the human immune system, many aspects of how the BM enables decade-long immunity against pathogens are still poorly understood. In this review, we discuss the relationship between BM survival niches and long-lasting humoral immunity, how intrinsic and extrinsic factors define memory cell longevity and show that the BM is also capable of adopting many responsibilities of a secondary lymphoid organ. Additionally, with more and more data on the differentiation and maintenance of memory T-cells and plasma cells upon vaccination in humans being reported, we discuss what factors determine the establishment of long-lasting immunological memory in the BM and what we can learn for vaccination technologies and antigen design. Finally, using these insights, we touch on how this holistic understanding of the BM is necessary for the development of modern and efficient vaccines against the pandemic SARS-CoV-2. Citation: Slamanig, S.A.; Nolte, M.A.
    [Show full text]
  • Immunological Memory Sleep After Vaccination Boosts
    Sleep after Vaccination Boosts Immunological Memory Tanja Lange, Stoyan Dimitrov, Thomas Bollinger, Susanne Diekelmann and Jan Born This information is current as of September 28, 2021. J Immunol 2011; 187:283-290; Prepublished online 1 June 2011; doi: 10.4049/jimmunol.1100015 http://www.jimmunol.org/content/187/1/283 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2011/06/01/jimmunol.110001 Material 5.DC1 References This article cites 50 articles, 6 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/187/1/283.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 28, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2011 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Sleep after Vaccination Boosts Immunological Memory Tanja Lange,*,† Stoyan Dimitrov,*,1 Thomas Bollinger,‡ Susanne Diekelmann,* and Jan Born* Sleep regulates immune functions. We asked whether sleep can influence immunological memory formation.
    [Show full text]
  • Differentiation of Memory B and T Cells Vandana Kalia1, Surojit Sarkar1, Tania S Gourley1, Barry T Rouse2 and Rafi Ahmed1
    Differentiation of memory B and T cells Vandana Kalia1, Surojit Sarkar1, Tania S Gourley1, Barry T Rouse2 and Rafi Ahmed1 In the past few years progress has been made in understanding recognize free pathogens, but instead identify infected the molecular mechanisms that underlie the initial generation, cells and exert effector functions including direct cyto- and the ensuing differentiation and maintenance, of humoral toxic effects on target cells and/or release of cytokines to and cellular immunity. Although B and T cell immunological inhibit growth or survival of the pathogen. CD4 T cells memory contribute to protective immunity through further provide help for antibody production and the fundamentally distinct effector functions, interesting analogies generation and maintenance of CD8 T-cell memory. are becoming apparent between the two memory Owing to their distinct complementary functions of tack- compartments. These include heterogeneity in function, ling free pathogens versus infected cells, it is important anatomical location and phenotype, which probably relate to for a successful vaccine strategy to stimulate both B and T differential environmental cues during the early priming events cell immunity. In this review, we discuss the distinct roles as well as the later differentiation phases. Detailed definition of played by humoral and cellular responses in protective the molecular and cellular signals involved in the development immunity and provide an overview of our current under- of immunological memory, and the relative contributions of standing of memory B and T cell differentiation. different memory subsets to protective immunity, remains an important goal. B-cell immunological memory Addresses Prolonged antibody production lasting for years after 1 1510 Clifton Road, Rollins Research Center G211, Emory University, infection or vaccination provides the first line of defense Atlanta, GA 30322, USA 2 Department of Microbiology and Immunology, The University of against pathogens and is key to humoral protection.
    [Show full text]
  • And Memory Response Post-Germinal Center B Cell
    Role of MHC Class II on Memory B Cells in Post-Germinal Center B Cell Homeostasis and Memory Response This information is current as Michiko Shimoda, Tao Li, Jeanene P. S. Pihkala and of September 27, 2021. Pandelakis A. Koni J Immunol 2006; 176:2122-2133; ; doi: 10.4049/jimmunol.176.4.2122 http://www.jimmunol.org/content/176/4/2122 Downloaded from References This article cites 56 articles, 32 of which you can access for free at: http://www.jimmunol.org/content/176/4/2122.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 27, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2006 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Role of MHC Class II on Memory B Cells in Post-Germinal Center B Cell Homeostasis and Memory Response1 Michiko Shimoda,2*† Tao Li,* Jeanene P. S. Pihkala,* and Pandelakis A. Koni2*‡ We investigated the role of B cell Ag presentation in homeostasis of the memory B cell compartment in a mouse model where a conditional allele for the ␤-chain of MHC class II (MHC-II) is deleted in the vast majority of all B cells by cd19 promoter-mediated expression of Cre recombinase (IA-B mice).
    [Show full text]
  • NK Cells and Immune ''Memory'' Joseph C
    NK Cells and Immune ''Memory'' Joseph C. Sun, Sandra Lopez-Verges, Charles C. Kim, Joseph L. DeRisi and Lewis L. Lanier This information is current as J Immunol 2011; 186:1891-1897; ; of September 27, 2021. doi: 10.4049/jimmunol.1003035 http://www.jimmunol.org/content/186/4/1891 Downloaded from References This article cites 88 articles, 33 of which you can access for free at: http://www.jimmunol.org/content/186/4/1891.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 27, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2011 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. NK Cells and Immune “Memory” Joseph C. Sun,*,1 Sandra Lopez-Verges,†,1 Charles C. Kim,‡ Joseph L. DeRisi,‡ and Lewis L. Lanier† Immunological memory is a hallmark of the adaptive persist for months to years, making immune memory unim- immune system. However, the ability to remember portant, or unnecessary, for short-lived cells comprising the and respond more robustly against a second encounter innate immune system, such as granulocytes and dendritic cells with the same pathogen has been described in organisms (DCs).
    [Show full text]
  • B Cell Memory: Understanding COVID-19
    ll Primer B cell memory: understanding COVID-19 Isaak Quast1 and David Tarlinton1,* 1Department of Immunology and Pathology, Monash University, 89 Commercial Road, Melbourne, VIC 3004, Australia *Correspondence: [email protected] https://doi.org/10.1016/j.immuni.2021.01.014 Immunological memory is a mechanism to protect us against reinfection. Antibodies produced by B cells are integral to this defense strategy and underlie virtually all vaccine success. Here, we explain how B cell mem- ory is generated by infection and vaccination, what influences its efficacy and its persistence, and how char- acterizing these parameters in the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will help achieve protective immunity through vaccination. Basic concepts of immunological memory the pathogen that triggered the response wherever it occurs. Creating a memory requires an event to change the status quo in Once the pathogen has been subdued and the response is effec- a way that persists beyond the event itself. For the immune sys- tively over, most pathogen-specific B and T cells die, but a small tem, events that induce memory include infections with viruses number of these recent combatants—B cells, T cells, and Ab- and bacteria as well as vaccinations. These challenges trigger secreting plasma cells (PCs)—persist as specialized, long-lived immune responses that can leave a footprint of their occurrence immune memory cells. that can then persist for decades. Spread over the many years of In responding to infection, our immune system uses infor- our lives, we will encounter many infectious threats—some once mation from the pathogen to determine the scale and and others multiple times.
    [Show full text]
  • Immunological Memory = Protective Immunity
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by RERO DOC Digital Library Cell. Mol. Life Sci. (2012) 69:1635–1640 DOI 10.1007/s00018-012-0972-y Cellular and Molecular Life Sciences MULTI-AUTHOR REVIEW Immunological memory = protective immunity Rolf M. Zinkernagel Received: 10 March 2012 / Revised: 13 March 2012 / Accepted: 13 March 2012 / Published online: 6 April 2012 Ó Springer Basel AG 2012 Abstract So-called ‘immunological memory’ is, in my Introduction view, a typical example where a field of enquiry, i.e. to understand long-term protection to survive reexposure to In the beginning was the fact that, once recovered from an infection, has been overtaken by ‘l’art pour l’art’ of ‘basic infection, the patient was resistant for life to disease by immunology’. The aim of this critical review is to point out the same infection. This, we call immunity. But since the some key differences between academic text book-defined 1880s, with the beginning of modern immunology, the immunological memory and protective immunity as term immunological memory was borrowed from ‘con- viewed from a co-evolutionary point of view, both from the ventional’ (neurological) memory to seemingly explain this host and the infectious agents. A key conclusion is that fact. We still do not understand whether ‘conventional’ ‘immunological memory’ of course exists, but only in brain memory is due to once perceived or thought = particular experimental laboratory models measuring always remembered, versus repeatedly reencountered, ‘quicker and better’ responses after an earlier immuniza- recollected, or dreamed. This controversy is the subject of tion.
    [Show full text]